0000912282-24-000658.txt : 20240917 0000912282-24-000658.hdr.sgml : 20240917 20240917143044 ACCESSION NUMBER: 0000912282-24-000658 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240917 DATE AS OF CHANGE: 20240917 EFFECTIVENESS DATE: 20240917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vesalius Cardiovascular Inc. CENTRAL INDEX KEY: 0001904804 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-492772 FILM NUMBER: 241303643 BUSINESS ADDRESS: STREET 1: 210 WEST BROADWAY, UNIT 200 CITY: VANCOUVER STATE: A1 ZIP: V5Y 3W2 BUSINESS PHONE: (604) 559-6162 MAIL ADDRESS: STREET 1: 210 WEST BROADWAY, UNIT 200 CITY: VANCOUVER STATE: A1 ZIP: V5Y 3W2 D/A 1 primary_doc.xml X0708 D/A LIVE 0001904804 Vesalius Cardiovascular Inc. 200 - 210 WEST BROADWAY VANCOUVER A1 BRITISH COLUMBIA, CANADA V5Y 3W2 (604) 559-6162 CANADA (FEDERAL LEVEL) None None Corporation true Peter Skarsgard 200 - 210 WEST BROADWAY Vancouver A1 BRITISH COLUMBIA, CANADA V5Y 3W2 Director Executive Officer Vincent Ledoux 200 - 210 WEST BROADWAY Vancouver A1 BRITISH COLUMBIA, CANADA V5Y 3W2 Director Executive Officer Other Technology Decline to Disclose 06b true 0000912282-23-000380 2023-09-18 true true true true Unit offering, each unit consisting of 1 common share and 1 warrant, each warrant may be exercised for 1 common share at CAD$6.00 prior to August 28, 2026 false 0 98836 37821 61015 Total remaining to be sold represents 13,650 warrants issued to US Investors, exercisable at CAD$6.00 until August 28, 2026. Does not include securities offered or sold under Reg S. Canadian dollars converted to USD at exchange rate of 1.3426. false 2 0 0 0 false Vesalius Cardiovascular Inc. /s/ Vincent Ledoux Vincent Ledoux CEO 2024-09-17